Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00796172 · ClinicalTrials.gov registry record · Phase 2

Evaluating the Effectiveness of a Computerized Medication Adherence System at Reducing Cardiovascular Disease Risk Factors

A Phase 2 study of Cardiovascular Diseases, sponsored by PHCC.

Completed
Registry status
Phase 2
Development phase
308
Enrollment target
1
Study location

NCT00796172 is a Phase 2 study of Cardiovascular Diseases that has completed, run by PHCC. The registered enrollment target is 308 participants, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00796172, a Phase 2 study of Cardiovascular Diseases, has completed, sponsored by PHCC.

COMPLETED
Registry status
Phase 2
Development phase
308 participants
Enrollment target
1
Study location

Study Summary

High blood pressure and high cholesterol are both causes of cardiovascular disease (CVD), and it is important for people with these conditions to adhere to their medication regimens. This study will evaluate the effectiveness of a computerized program that provides individualized feedback to participants and their doctors for increasing medication adherence among people at risk of developing CVD.

Conditions Studied

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Medication Adherence System (MAS)

Study Locations (1)

Colorado

  • PHCC LP - Pueblo

Trial Details

FieldValue
Enrollment Target 308 participants
Start Date 2008-12
Est. Completion 2010-06
Phase Phase 2

Sponsor

PHCC

2 total trials

What the Registry Record Tells You About NCT00796172

The ClinicalTrials.gov registry entry for NCT00796172 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 308 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The listed sponsor is PHCC, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT00796172 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT00796172 about?

NCT00796172 is a clinical study titled "Evaluating the Effectiveness of a Computerized Medication Adherence System at Reducing Cardiovascular Disease Risk Factors". High blood pressure and high cholesterol are both causes of cardiovascular disease (CVD), and it is important for people with these conditions to adhere to their medication regimens. This study will evaluate the effectiveness of a computerized program that provides individualized feedback to partici...

What is the current status of trial NCT00796172?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 308 participants. The study started on 2008-12. Estimated completion is 2010-06.

What conditions does trial NCT00796172 study?

This clinical trial studies the following conditions: Cardiovascular Diseases.

What interventions are being tested in trial NCT00796172?

The interventions under investigation include: Usual Care (BEHAVIORAL), Medication Adherence System (MAS) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00796172?

This trial is sponsored by PHCC, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00796172 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.